CPhI logo
  • Products
  • Suppliers
  • Sourcing Requests
  • 中文站
  • Sign in Join free
Post Sourcing Request Post Sourcing Request Sourcing Request List Exhibition
  • Home
  • Products
  • Suppliers
  • Content Hub
  • Industry Insights
  • Events
  • Service & Membership
  • For Suppliers

    My Account

    My Online Store

    My EZSourcing

    View Sourcing Requests

    Customer Service

  • For Buyer

    Search Products & Suppliers

    Products Directory Suppliers Discovery Post EZSourcing

    Service

    Buyer Sourcing Event Contact Us

    Quick links

    My Favorites Recent Visit History
  • Industry Data
  • Features
  • Market News
  • Products Guide
  • Brand Story
You are here:   Industry Insights > Market News

Market News

  • Cluster Headaches Can Defy Diagnosis But Respond to Treatment Market news drugs.comJanuary 03, 2017
    Cluster headaches are extremely painful, but treatable and preventable, one neurologist says.
  • Lupin receives approval for generic Livalo tablets Market news expressbpdJanuary 03, 2017
    The tablets are indicated as an adjunctive therapy to diet to reduce elevated total cholesterol
  • Metformin Still Best Choice for First Type 2 Diabetes Treatment Market news drugs.comJanuary 03, 2017
    Newly updated guidelines reaffirm that metformin is the first-line drug for people with type 2 diabetes, and that several other medications -- including newer ones -- can be added if needed.
  • Personalized medicine market analysis and value forecast snapshot 2016-2026 Market news pharmaasiaJanuary 03, 2017
    Funds worth EUR 1 billion have been invested by the EU as of 2015 to focus on the development of personalized medicine.
  • Natco Pharma launches first generic version of hepatitis C tabs in Nepal Market news expressbpdJanuary 03, 2017
    Natco will market Sofosbuvir 400mg/Velpatasvir 100mg under the brand name VELPANAT
  • Recipharm Gains Approval for Acquisition of Kemwell Indian Ops Market news contractpharmaJanuary 03, 2017
    Includes pharma manufacturing and development operations in Bengaluru.
  • Biogen’s SPINRAZA Wins FDA Approval Market news contractpharmaJanuary 03, 2017
    Biogen’s SPINRAZA (nusinersen) has been approved by the FDA for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.
  • A Countdown of 10 Memorable Moments From 2016 Market news lillyJanuary 03, 2017
    NASA’s spacecraft Juno successfully entered Jupiter’s orbit, Tiger numbers rose for the first time in a century, cars are driving themselves...
  • Top 20 World Pharma News of 2016 Market news worldpharmanewsJanuary 03, 2017
    Look back at the most prominent moments from the year 2016. We are proud to announce the 20 most popular World Pharma News from 2016, the most commonly viewed news according the collected web statistics.
  • Sihuan Pharmaceutical(0460.HK): Respond to the special directives to combat illegal medical aesthetics services, Advocate 'Positive Energy' of China's Medical Aesthetics Industry Market news ACN NewswireSeptember 09, 2021
    HONG KONG, Aug 11, 2021 - (ACN Newswire) - On June 10, 2021, the National Health Commission, leading eight ministries and commissions, issued the "Notice on Distributing the Special Rectification Work Plan for Combating Illegal Medical Aesthetic Services.
Previous page 1 2 3 4 5 6 7 8 ... 4092 4093 Next page

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPhI China
P-MEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
  • Copyright 2006-2022 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
  • Links:
    CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
  • Follow Us:

  • CPhI logo Pharma Sources Insight JUNE2022
  • PharmaSources@imsinoexpo.com
  • +86-13621645194
  • We Want Your Feedback